2022
DOI: 10.3390/cancers14020281
|View full text |Cite
|
Sign up to set email alerts
|

Recurrent Spliceosome Mutations in Cancer: Mechanisms and Consequences of Aberrant Splice Site Selection

Abstract: Splicing alterations have been widely documented in tumors where the proliferation and dissemination of cancer cells is supported by the expression of aberrant isoform variants. Splicing is catalyzed by the spliceosome, a ribonucleoprotein complex that orchestrates the complex process of intron removal and exon ligation. In recent years, recurrent hotspot mutations in the spliceosome components U1 snRNA, SF3B1, and U2AF1 have been identified across different tumor types. Such mutations in principle are highly … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 66 publications
(172 reference statements)
0
6
0
Order By: Relevance
“…Among them, spliceosome in uences cancer up to an extent. Research has shown that certain components of spliceosomes, including U1 snRNA, SF3B1, and U2AF1, may be related to tumors, which are critically involved in cancer progression [20,21]. A study indicates that chronic cerebral hypoperfusion (CCH) can simultaneously trigger the coagulation and complement cascade in a new Alzheimer's disease mouse model brain, potentially expediting AD pathology.…”
Section: Discussionmentioning
confidence: 99%
“…Among them, spliceosome in uences cancer up to an extent. Research has shown that certain components of spliceosomes, including U1 snRNA, SF3B1, and U2AF1, may be related to tumors, which are critically involved in cancer progression [20,21]. A study indicates that chronic cerebral hypoperfusion (CCH) can simultaneously trigger the coagulation and complement cascade in a new Alzheimer's disease mouse model brain, potentially expediting AD pathology.…”
Section: Discussionmentioning
confidence: 99%
“…These findings implied that the WDR4 rs6586250 T allele could regulate the expression of multiple surrounding genes. RNA splicing is essential for generating mature messenger RNA (mRNA) and regulating gene expression, thereby affecting cellular processes and cell fates, and is catalyzed by a ribonucleoprotein complex called the spliceosome 47 . U2AF1, the subunit of the U2 auxiliary factor (U2AF) heterodimer and an indispensable component of the spliceosome, has the ability to specifically recognize the AG dinucleotide of the 3' splice sites and promote the process of RNA splicing.…”
Section: Discussionmentioning
confidence: 99%
“…U2AF1, the subunit of the U2 auxiliary factor (U2AF) heterodimer and an indispensable component of the spliceosome, has the ability to specifically recognize the AG dinucleotide of the 3' splice sites and promote the process of RNA splicing. Furthermore, mutations in U2AF1 were associated with hematological malignancies and myelodysplasia syndromes 47 . According to our analysis, a low expression level of U2AF1 might affect the activity or efficiency of RNA splicing, leading to the possibility of tumorigenesis.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, mutations in other proteins and non-coding RNAs in splicing regulation with lower frequency have been shown to play important roles in myeloid neoplasms, too. Mutations in genes encoding the U1 and U11 snRNAs responsible for recognition of the 5′ss in the major and minor spliceosomes were found in CLL and other cancer types [ 62 , 63 ]. Factors in the hnRNP family function to repress splicing as opposed to SR proteins [ 21 ], and mutations in HNRNPH1 are found to be associated with adverse outcomes in mantle cell lymphoma [ 64 ].…”
Section: The Discovery and Pathogenic Roles Of Splicing Factor Mutati...mentioning
confidence: 99%